Table 1 Demographic and clinical details of recruited subjects.
From: Three serum metabolite signatures for diagnosing low-grade and high-grade bladder cancer
Parameters | Discovery set (Race: Chinese) | Validation set (Race: Chinese) | ||||
|---|---|---|---|---|---|---|
LGBC | HGBC | Healthy | LGBC | HGBC | Healthy | |
Sample size | 34 | 34 | 30 | 26 | 26 | 22 |
Gender (male/female) | 29/5 | 30/4 | 24/5 | 22/4 | 21/5 | 17/4 |
BMI (median, range) | 23.1 (17.1–27.6) | 22.3 (16.6–28.2) | 23.5 (17.5–27.7) | 23.5 (16.7–28.2) | 22.7 (16.3–27.4) | 23.6 (17.0–28.4) |
Hematuria | 4 (11.7%) | 5 (14.7%) | 0 | 3 (11.5%) | 3 (11.5%) | 0 |
Medications | 0 | 0 | 0 | 0 | 0 | 0 |
BC stage | ||||||
Ta | 2 (5.9%) | 2 (5.9%) | — | 1 (3.8%) | 2 (7.7%) | — |
T1 | 19 (55.9%) | 6 (17.67%) | — | 15 (57.7%) | 4 (15.3) | — |
T2 | 13 (38.2%) | 17 (50.0%) | — | 10 (38.5%) | 13 (50.0%) | — |
T3 | — | 7 (20.6%) | — | — | 5 (19.3%) | — |
T4 | — | 2 (5.9%) | — | — | 2 (7.7%) | — |
Smoking habit | ||||||
Smokers | 23 (67.6%) | 21 (61.8%) | 22 (73.3%) | 17 (65.4%) | 16 (61.5%) | 15 (68.2%) |
Ex-smokers | 3 (8.3%) | 5 (14.7%) | 0 | 2 (7.7%) | 2 (7.7%) | 0 |
Nonsmokers | 8 (23.5%) | 8 (23.5%) | 8 (26.7%) | 7 (26.9%) | 8 (30.8%) | 7 (31.8%) |
